Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting Jul 19, 2023 | Uncategorized
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition Jul 10, 2023 | Uncategorized
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy Jul 10, 2023 | Uncategorized
Novel cytokine-antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma Jul 7, 2023 | Uncategorized
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells Jul 7, 2023 | Uncategorized
